News
GLP-1 drugs like Ozempic help with weight loss, but how do they stack up against bariatric surgery? A new study breaks it ...
Missed Out on Eli Lilly's 480% Gains Over the Past 5 Years? These GLP-1 Stocks Still Have Plenty of Upside.
Wellness influencer Janelle Rohner has seen the internet’s criticism after revealing she micro-dosed GLP-1 to lose weight.
She lost 250 pounds and thought her journey was over... but then she discovered something most people don't talk about.
Zealand Pharma announces positive topline results from 28-week Phase 1b trial with GLP-1/GLP-2 receptor dual agonist ...
A new study reveals that bariatric surgery results in significantly greater weight loss compared to popular GLP-1 drugs.
Patients with type 2 diabetes had a lower risk of glaucoma when they used glucagon-like peptide 1 (GLP-1) receptor agonists across multiple studies.
The companies are working together to make it easier for companies to offer health plans that include these medications.
Revolutionizing Access to Modern Weight-Care SolutionsSan Diego, CA, June 18, 2025 (GLOBE NEWSWIRE) -- OnlineSemaglutide.org, ...
In patients with moderate peripheral artery disease, use of GLP-1 RAs increases the likelihood of more favorable cardiovascular and major limb outcomes.
A study presented at the American Society for Metabolic and Bariatric Surgery highlighted that bariatric surgeries, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results